Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii

被引:50
|
作者
Giacometti, A
Cirioni, O
Del Prete, MS
Barchiesi, F
Paggi, AM
Petrelli, E
Scalise, G
机构
[1] Univ Ancona, Inst Infect Dis & Publ Hlth, Azienda Osped Umberto 1, I-60121 Ancona, Italy
[2] San Salvatore Hosp, Dept Infect Dis, Pescara, Italy
关键词
D O I
10.1093/jac/46.5.807
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of buforin II, cecropin P1, indolicidin, magainin II and ranalexin, alone and in combination with eight clinically used antimicrobial agents was investigated against 12 multidrug-resistant strains of Acinetobacter baumannii isolated from immunocompromised patients, Antimicrobial activities were measured by MIG, MBC and viable count, The peptides had a varied range of inhibitory values: overall, the organisms were more susceptible to buforin II (MIC range 0.25-16 mg/L), cecropin P1 (0.50-32 mg/L) and magainin II (0.50-16 mg/L), Synergy occurred when magainin II was combined with p-lactam antibiotics.
引用
收藏
页码:807 / 810
页数:4
相关论文
共 50 条
  • [1] Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates
    Seifert, Harald
    Stefanik, Danuta
    Wisplinghoff, Hilmar
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (05) : 1099 - 1100
  • [2] Antimicrobial and antibiofilm activities of desloratadine against multidrug-resistant Acinetobacter baumannii
    Eduvirgem, Junio
    Rossato, Luana
    Melo, Andressa Lf
    Valiente, Anna Cm
    Placa, Luiz F.
    Wender, Heberton
    Vaz, Marcia Sm
    Ribeiro, Suzana M.
    Simionatto, Simone
    [J]. FUTURE MICROBIOLOGY, 2023, 18 (01) : 15 - 25
  • [3] Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates
    Kiratisin, Pattarachai
    Apisarnthanarak, Anucha
    Kaewdaeng, Srirumpa
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (03) : 243 - 246
  • [4] In Vitro and In Vivo Antimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii
    Antunes, Luisa C. S.
    Imperi, Francesco
    Minandri, Fabrizia
    Visca, Paolo
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5961 - 5970
  • [5] Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates
    Piewngam, Pipat
    Kiratisin, Pattarachai
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (05) : 396 - 401
  • [6] Nosocomial infection of multidrug-resistant Acinetobacter baumannii in Thailand
    Anudit, Chanihcha
    Kooltheat, Nateelak
    Potup, Pachuen
    Sranujit, Rungnapa Pankla
    Usuwanthim, Kanchana
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (10) : 1161 - 1163
  • [7] Minocycline activity against clinical isolates of multidrug-resistant Acinetobacter baumannii
    Adibhesami, H.
    Douraghi, M.
    Rahbar, M.
    Abdollahi, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (11) : E79 - E80
  • [8] Efficacy of Mastoparan-AF alone and in combination with clinically used antibiotics on nosocomial multidrug-resistant Acinetobacter baumannii
    Lin, Chun-Hsien
    Lee, Mong-Chuan
    Tzen, Jason T. C.
    Lee, Hsien-Ming
    Chang, Sam-Min
    Tu, Wu-Chun
    Lin, Chuen-Fu
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2017, 24 (05) : 1023 - 1029
  • [9] Secapin: a promising antimicrobial peptide against multidrug-resistant Acinetobacter baumannii
    Rad, Zohreh Sadeghi
    Farahmand, Mahnaz
    Kavousi, Mahsa
    [J]. GMS HYGIENE AND INFECTION CONTROL, 2024, 19
  • [10] EMERGENCE OF MULTIDRUG-RESISTANT ISOLATES OF ACINETOBACTER-BAUMANNII
    OKPARA, AU
    MASWOSWE, JJ
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (21): : 2671 - 2675